Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 37 Records) |
Query Trace: Syndrome and CYP2C9[original query] |
---|
Xenobiotic sensor- and metabolism-related gene variants in environmental sensitivity-related illnesses: a survey on the Italian population. Oxidative medicine and cellular longevity 2013 2013 831969. Caccamo Daniela, Cesareo Eleonora, Mariani Serena, Raskovic Desanka, Ientile Riccardo, Currò Monica, Korkina Liudmila, De Luca Chia |
Genetic variants associated with phenytoin-related severe cutaneous adverse reactions. JAMA 2014 Aug 312 (5): 525-34. Chung Wen-Hung, Chang Wan-Chun, Lee Yun-Shien, Wu Ying-Ying, Yang Chih-Hsun, Ho Hsin-Chun, Chen Ming-Jing, Lin Jing-Yi, Hui Rosaline Chung-Yee, Ho Ji-Chen, Wu Wei-Ming, Chen Ting-Jui, Wu Tony, Wu Yih-Ru, Hsih Mo-Song, Tu Po-Hsun, Chang Chen-Nen, Hsu Chien-Ning, Wu Tsu-Lan, Choon Siew-Eng, Hsu Chao-Kai, Chen Der-Yuan, Liu Chin-San, Lin Ching-Yuang, Kaniwa Nahoko, Saito Yoshiro, Takahashi Yukitoshi, Nakamura Ryosuke, Azukizawa Hiroaki, Shi Yongyong, Wang Tzu-Hao, Chuang Shiow-Shuh, Tsai Shih-Feng, Chang Chee-Jen, Chang Yu-Sun, Hung Shuen-Iu, , |
[Predictive genomic markers for severe adverse drug reactions]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 2015 135 (4): 589-95. Saito Yoshiro, Kodama Susumu, Sugiyama Emiko, Nakamura Ryosu |
Impact of CYP2C9 and VKORC1 genetic polymorphisms upon warfarin dose requirements in Egyptian patients with acute coronary syndrome. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2015 Jul 26 (5): 499-504. Ghozlan Manal F, Foad Dina A, Darwish Yasser W, Saad Abeer |
Pharmacogenetic approach to losartan in Marfan patients: a starting point to improve dosing regimen? Drug metabolism and personalized therapy 2016 Jul . Falvella Felicia Stefania, Marelli Susan, Cheli Stefania, Montanelli Stefano, Viecca Federico, Salvi Lucia, Ferrara Alfio, Clementi Emilio, Trifirò Giuliana, Pini Alessand |
Associations between HLA class I and cytochrome P450 2C9 genetic polymorphisms and phenytoin-related severe cutaneous adverse reactions in a Thai population. Pharmacogenetics and genomics 2016 May 26 (5): 225-34. Tassaneeyakul Wichittra, Prabmeechai Napat, Sukasem Chonlaphat, Kongpan Thachanan, Konyoung Parinya, Chumworathayi Pansu, Tiamkao Somsak, Khunarkornsiri Usanee, Kulkantrakorn Kongkiat, Saksit Niwat, Nakkam Nontaya, Satapornpong Patompong, Vannaprasaht Suda, Sangviroon Alisara, Mahasirimongkol Surakameth, Wichukchinda Nuanjun, Rerkpattanapipat Ticha, Tassaneeyakul Wongwiw |
Influence of genetic and non-genetic factors on phenytoin-induced severe cutaneous adverse drug reactions. European journal of clinical pharmacology 2017 Apr . Yampayon Kittika, Sukasem Chonlaphat, Limwongse Chanin, Chinvarun Yotin, Tempark Therdpong, Rerkpattanapipat Ticha, Kijsanayotin Pornpim |
Angiotensin-Converting Enzyme Inhibitors' Influence on Antiplatelet Therapy of Clopidogrel in ACS. Clinical laboratory 2016 Oct 62 (10): 1911-1918. Yang Shuo, Cui Chanjuan, Zhang Jie, Qiao R |
Genotyping of six clopidogrel-metabolizing enzyme polymorphisms has a minor role in the assessment of platelet reactivity in patients with acute coronary syndrome. Anatolian journal of cardiology 2017 Feb . García-Lagunar María Henar, Consuegra-Sánchez Luciano, Conesa-Zamora Pablo, Ruiz-Cosano Javier, Soria-Arcos Federico, García de Guadiana Luis, Vivar Pedro Cano, Castillo-Moreno Juan Antonio, Melgarejo-Moreno Anton |
Association of CYP2C9*3 with phenytoin-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review and meta-analysis. Journal of clinical pharmacy and therapeutics 2018 Jun 43 (3): 408-413. Wu X, Liu W, Zhou |
A Prediction Algorithm for Drug Response in Patients with Mesial Temporal Lobe Epilepsy Based on Clinical and Genetic Information. PloS one 2017 12 (1): e0169214. Silva-Alves Mariana S, Secolin Rodrigo, Carvalho Benilton S, Yasuda Clarissa L, Bilevicius Elizabeth, Alvim Marina K M, Santos Renato O, Maurer-Morelli Claudia V, Cendes Fernando, Lopes-Cendes Isc |
Add-on stiripentol elevates serum valproate levels in patients with or without concomitant topiramate therapy. Epilepsy research 2017 1 130 7-12. Jogamoto Toshihiro, Yamamoto Yoshiaki, Fukuda Mitsumasa, Suzuki Yuka, Imai Katsumi, Takahashi Yukitoshi, Inoue Yushi, Ohtsuka Yo |
The role of pharmacogenetics of cytochrome P450s in phenytoin-induced DRESS syndrome. Central-European journal of immunology 2018 43 (2): 220-221. Ya?ar Üm |
CYP2C9 polymorphisms in epilepsy: influence on phenytoin treatment. Pharmacogenomics and personalized medicine 2018 4 11 51-58. Silvado Carlos Eduardo, Terra Vera Cristina, Twardowschy Carlos Alexand |
Mutations in CYP2C9 and/or VKORC1 haplotype are associated with higher bleeding complications in patients with Budd-Chiari syndrome on warfarin. Hepatology international 2019 1 13 (2): 214-221. Shukla Akash, Jain Abhinav, Kahalekar Vinit, Bendkhale Sheetal, Gogtay Nithya, Thatte Urmila, Bhatia Shob |
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing: 2020 Update. Clinical pharmacology and therapeutics 2020 Aug . Karnes Jason H, Rettie Allan E, Somogyi Andrew A, Huddart Rachel, Fohner Alison E, Formea Christine M, Ta Michael Lee Ming, Llerena Adrian, Whirl-Carrillo Michelle, Klein Teri E, Phillips Elizabeth J, Mintzer Scott, Gaedigk Andrea, Caudle Kelly E, Callaghan John |
Variants in ADRB1 and CYP2C9: Association with Response to Atenolol and Losartan in Marfan Syndrome. The Journal of pediatrics 2020 6 222 213-220.e5. Van Driest Sara L, Sleeper Lynn A, Gelb Bruce D, Morris Shaine A, Dietz Harry C, Forbus Geoffrey A, Goldmuntz Elizabeth, Hoskoppal Arvind, James Jeanne, Lee Teresa M, Levine Jami C, Li Jennifer S, Loeys Bart L, Markham Larry W, Meester Josephina A N, Mital Seema, Mosley Jonathan D, Olson Aaron K, Renard Marjolijn, Shaffer Christian M, Sharkey Angela, Young Luciana, Lacro Ronald V, Roden Dan |
Genetic Association of Co-Trimoxazole-Induced Severe Cutaneous Adverse Reactions Is Phenotype-Specific: HLA Class I Genotypes and Haplotypes. Clinical pharmacology and therapeutics 2020 May . Sukasem Chonlaphat, Pratoomwun Jirawat, Satapornpong Patompong, Klaewsongkram Jettanong, Rerkpattanapipat Ticha, Rerknimitr Pawinee, Lertpichitkul Pattamon, Puangpetch Apichaya, Nakkam Nontaya, Konyoung Parinya, Khunarkornsiri Usanee, Disphanurat Wareeporn, Srisuttiyakorn Chutika, Pattanacheewapull Oranuch, Kanjanawart Sirimas, Kongpan Thachanan, Chumworathayi Pansu, Saksit Niwat, Bruminhent Jackrapong, Tassaneeyakul Wichittra, Chantratita Wasun, Pirmohamed Munir, |
Multimorbidity, polypharmacy, and drug-drug-gene interactions following a non-ST elevation acute coronary syndrome: analysis of a multicentre observational study. BMC medicine 2020 11 18 (1): 367. Turner R M, de Koning E M, Fontana V, Thompson A, Pirmohamed |
Cardiovascular Pharmacogenomics: An Update on Clinical Studies of Antithrombotic Drugs in Brazilian Patients. Molecular diagnosis & therapy 2021 8 25 (6): 735-755. Hirata Thiago Dominguez Crespo, Dagli-Hernandez Carolina, Genvigir Fabiana Dalla Vecchia, Lauschke Volker Martin, Zhou Yitian, Hirata Mario Hiroyuki, Hirata Rosario Dominguez Cres |
Association of HLA-B*51:01, HLA-B*55:01, CYP2C9*3, and Phenytoin-Induced Cutaneous Adverse Drug Reactions in the South Indian Tamil Population. Journal of personalized medicine 2021 8 11 (8): . John Shobana, Balakrishnan Karuppiah, Sukasem Chonlaphat, Anand Tharmarajan Chinnathambi Vijay, Canyuk Bhutorn, Pattharachayakul Sutthipo |
Cytochrome P450-Catalyzed Metabolism of Cannabidiol to the Active Metabolite 7-Hydroxy-Cannabidiol. Drug metabolism and disposition: the biological fate of chemicals 2021 7 49 (10): 882-891. Beers Jessica L, Fu Dong, Jackson Klarissa |
The effect of CYP2D6 and CYP2C9 gene polymorphisms on the efficacy and safety of the combination of tramadol and ketorolac used for postoperative pain management in patients after video laparoscopic cholecystectomy. Drug metabolism and personalized therapy 2021 7 . Muradian Andranik Alexandrovich, Sychev Dmitry Alekseevich, Blagovestnov Dmitry Alekseevich, Sozaeva Zhannet Alimovna, Akmalova Kristina Anatolyevna, Zastrozhin Michael Sergeevich, Kerimova Leyla Nabievna, Koroshvili Vadim Teymurazovich, Epifanova Irina Alexandrov |
HLA-B*13 :01 Is a Predictive Marker of Dapsone-Induced Severe Cutaneous Adverse Reactions in Thai Patients. Frontiers in immunology 2021 5 12 661135. Satapornpong Patompong, Pratoomwun Jirawat, Rerknimitr Pawinee, Klaewsongkram Jettanong, Nakkam Nontaya, Rungrotmongkol Thanyada, Konyoung Parinya, Saksit Niwat, Mahakkanukrauh Ajanee, Amornpinyo Warayuwadee, Khunarkornsiri Usanee, Tempark Therdpong, Wantavornprasert Kittipong, Jinda Pimonpan, Koomdee Napatrupron, Jantararoungtong Thawinee, Rerkpattanapipat Ticha, Wang Chuang-Wei, Naisbitt Dean, Tassaneeyakul Wichittra, Ariyachaipanich Manasalak, Roonghiranwat Thapana, Pirmohamed Munir, Chung Wen-Hung, Sukasem Chonlaph |
Polymorphisms of genes related to phase-I metabolic enzymes affecting the clinical efficacy and safety of clopidogrel treatment. Expert opinion on drug metabolism & toxicology 2021 5 17 (6): 685-695. Alkattan Abdullah, Alsalameen Em |
The effect of CYP2D6 and CYP2C9 gene polymorphisms on the efficacy and safety of the combination of tramadol and ketorolac used for postoperative pain management in patients after video laparoscopic cholecystectomy. Drug metabolism and personalized therapy 2022 4 37 (1): 27-34. Muradian Andranik Alexandrovich, Sychev Dmitry Alekseevich, Blagovestnov Dmitry Alekseevich, Sozaeva Zhannet Alimovna, Akmalova Kristina Anatolyevna, Zastrozhin Michael Sergeevich, Kerimova Leyla Nabievna, Koroshvili Vadim Teymurazovich, Epifanova Irina Alexandrov |
null. Drug metabolism and disposition: the biological fate of chemicals 2023 9 . Youhao Chen, Yaobin Lin, Shaoxing Guan, Zerui Zhao, Daren Lin, Jin Guan, Chengzhi Zhou, Junling Liu, Xiaolong Cao, Zhichao Lin, Diyao Chen, Jianbiao Shang, Weijian Zhang, Huohui Chen, Likun Chen, Shudong Ma, Lijia Gu, Jian Zhao, Min Huang, Xueding Wang, Hao Lo |
Genetic variants in epoxyeicosatrienoic acid processing and degradation pathways are associated with gestational diabetes mellitus. Nutrition journal 2023 6 22 (1): 31. Siyu Lai, Dandan Yan, Jie Xu, Xiangtian Yu, Jingyi Guo, Xiangnan Fang, Mengyang Tang, Rong Zhang, Hong Zhang, Weiping Jia, Mingjuan Luo, Cheng |
CYP2C9 Polymorphisms and the Risk of Cardiovascular Events in Patients Treated with Clopidogrel: Combined Data from the POPular Genetics and POPular AGE Trials. American journal of cardiovascular drugs : drugs, devices, and other interventions 2023 2 23 (2): 165-172. van den Broek Wout W A, Mani Nabil, Azzahhafi Jaouad, Ten Berg Jurriën |
Influence of CYP450 Enzymes and ABCB1 Polymorphisms on Clopidogrel Response in Moroccan Patients with Acute Coronary Syndromes. Pharmacogenomics and personalized medicine 2023 10 16 901-909. Ismail Mouhrach, Laila Bouguenouch, Adil Kamal, Abbassi Meriame, Nada El Khorb, Mohammed El Azami El Idrissi, Hafid Akoudad, Hicham Bekka |
- Page last reviewed:Feb 1, 2024
- Page last updated:Mar 25, 2024
- Content source: